glp-1 and perimenopause GLP-1s Hormone Therapy: A Game-Changing Duo for Menopause Belly Fat GLP-1 and Perimenopause: Clinical Evidence

Frequently Asked Questions Do patients regain weight after stopping GLP-1 medications long-term

Sitagliptin alters bone composition in high-fat-fed mice

In a study, as the levels of homocysteine improved, the participants blood pressure, a marker of heart health, also decreased

One study of 100 people who took MSM demonstrated the effectiveness of this supplement in helping to ease inflammation and lessen joint pain and stiffness

Excess weight is associated with venous stasis, particularly in the lower limbs, and obesity is a well-established risk factor for venous thromboembolism

Not recommended in case of kidney, heart and cardiovascular disease, neither for people who suffer from diseases accompanied with seizures